A244

BIOLOGICAL2 trials

Sponsors

U.S. Army Medical Research and Development Command

Conditions

AIDS VirusHIVHuman Immunodeficiency Virus (HIV)

Phase 1

HIV Vaccine in HIV-uninfected Adults

CompletedNCT04658667

U.S. Army Medical Research and Development CommandHIV

Start: 2022-02-03End: 2024-07-01Updated: 2025-07-30

Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults

CompletedNCT05423418

U.S. Army Medical Research and Development CommandAIDS Virus, Human Immunodeficiency Virus (HIV)

Start: 2022-09-08End: 2024-10-29Updated: 2026-02-09